Insomnia & Mental Health
Good sleep health is essential to sustain optimal mental and physical well-being. Conversely, poor sleep health and insomnia increase the risk of adverse health outcomes in mental, physical, and occupational domains. The overarching goals of the Insomnia and Mental Health research team are to improve our understanding of the psychological and biological underpinnings of insomnia phenotypes and develop more effective and more personalized treatments. This program will generate new knowledge about the prevalence, course, and burden of poor sleep health and insomnia in Canada, while seeking to identify reliable sleep predictors of long-term mental health outcomes. It will also expand our understanding of different insomnia phenotypes along several dimensions (e.g., autonomic arousal, brain activity, and mental health). This research will inform clinical practice with regard to how we can optimize insomnia treatment outcomes with personalized interventions as a function of insomnia phenotypes. It will generate novel evidence-based and culturally adapted treatments for insomnia, including new sleep intervention training tools for health care providers serving First Nations, Métis, and Inuit communities that are co-designed with these communities. By enhancing our understanding of the interrelationships of poor sleep, insomnia and adverse mental health, this research has the potential to reveal new avenues for improving both the sleep and the mental health of Canadians.
Team Leads
-
Charles Morin
NOMINATED PRINCIPAL INVESTIGATOR
-
Rébecca Robillard
PRINCIPAL INVESTIGATOR
-
Colleen Carney
PRINCIPAL INVESTIGATOR
-
Jean-Philippe Chaput
PRINCIPAL INVESTIGATOR
-
Thien Thanh Dang-Vu
PRINCIPAL INVESTIGATOR
-
Judith Davidson
CO-INVESTIGATOR
Meet The Team
-
Célyne Bastien, PhD, Université Laval
Julie Carrier, PhD, Université de Montréal
David Gardner, PharmD, MSc, Dalhousie University
Ojistoh Horn, MD, MSc, Akwesasne First Nation
Andrew Lim, MD, University of Toronto
Jean-Marc Lina, PhD, École de Technologie Supérieure
Dominique Lorrain, PhD, Université Sherbrooke
Amrita Roy, MD, PhD, Queen’s University
Shayna Watson, MD, Queen’s University
Magdy Younes, PhD, University of Manitoba
-
Lydi-Anne Vézina-Im, PhD, Université Laval
Andrée-Ann Baril, PhD, McGill University
Imaan Bayoumi, MD, Queen’s University
Alan Douglass, MD, University of Ottawa
Stuart Fogel, PhD, University of Ottawa
Mohamad Forouzanfar, PhD, École de Technologie Supérieure
Ariel Garten, InteraXon
Jordan Hovdebo, PhD, National Research Council of Canada
Hans Ivers, PhD, Université Laval
Elliott Lee, MD, University of Ottawa
Kathleen Lemieux, MD, PhD, Université Laval
Colin Shapiro, MD, University of Health Network
Eleftherios Soleas, PhD, Queen’s University
Paniz Tavakoli, PhD, University of Ottawa
Lynda Bélanger, PhD, Laval University
-
Loïc Barbaux, PhD, Concordia University
Karianne Dion, PhD, University of Ottawa
Maryam El Gewely, PhD, Université Laval
Sarah Fakroune, PhD, Université Laval
Katherine Fretz, PhD, Queen’s University
Samuel Gillman, BSc, Concordia University
Anne Léonard, PhD, Université Sherbrooke
Onkar Marway, PhD, Toronto Metropolitan University
Aurore Perrault, Post-Doc, Concordia University
Meggan Porteous, PhD candidate, University of Ottawa
-
Mary Bartram, Mental Health Commission of Canada
Dave Gallson, Mood Disorders Society of Canada
Benjamin Leikin, Ottawa Public Health
Karen Roberts, Public Health Agency of Canada
-
Riana Rakotoarimananjara
Michael Samson
Research Projects
Prevalence and Burden of Insomnia and Poor Sleep Health in Canada (Leads: C. Morin, J.-P. Chaput)
Create a national cohort study of insomnia and sleep health
Establish a Canadian Sleep Health Registry
Improve the surveillance of insomnia and quantify its burden in Canada
2. Insomnia Phenotypes (Leads: R. Robillard, T. Dang-Vu)
Apply advanced signal processing and artificial intelligence methods to expand our understanding of insomnia phenotypes based on polysomnography
Investigate how different components of insomnia phenotypes predict treatment response to cognitive behavioural therapy for insomnia (CBT-I)
3. Treatment Development and Enhancement
Evaluate a novel multi-domain intervention converging CBT-I, fatigue management and pharmacotherapy for people with comorbid depression and/or anxiety disorders a function of insomnia phenotypes (Leads: C. Carney, C. Morin)
Enhance insomnia care with Akwesasne Mohawk Nation (Leads: J. Davidson, O. Horn)